Process for enantiomeric separation of racemic dihydro-1,3,5 triazines via preferential crystallization

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8742102
APP PUB NO 20120071655A1
SERIAL NO

13138728

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A new process for the enantiomeric separation of racemic 3,6-dihydro-1,3,5-triazine derivatives for the treatment of disorders associated with insulin-resistance syndrome, by preferential crystallization.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
POXELIMMEUBLE LE SUNWAY 259/261 AVENUE JEAN JAURÈS LYON 69007

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cardinael, Pascal Isneauville, FR 1 3
Coquerel, Gérard Boos, FR 16 12
Cravo, Daniel Montesson, FR 33 169
Helmreich, Matthias Heidelberg, DE 5 9
Levilain, Guillaume Deville les Rouen, FR 11 18
Niesert, Claus-Peter Seehelm-Jugenheim, DE 7 75
Wacharine-Antar, Saoussen Menzel Bouzelfa, TN 1 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 3, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00